Our mission is to advance our understanding in the cellular and molecular mechanisms of common and rare ocular diseases. Research in ocular pathobiology crosses a wide range of fields, including but not limited to inflammation, neurodegeneration, angiogenesis/vascular dysfunction, immunology, metabolism, ophthalmic imaging, machine learning, neuroprotection, gene therapy, stem cell biology, and regeneration. We aim to engage an active community of basic scientists and clinicians, to promote novel clinical, mechanistic, and translational research, to create a platform for exchange of ideas, development and strengthening of collaborations, dissemination of scientific knowledge, and to foster the growth of the next generation of ocular researchers through inspiring mentoring and education.
As a result of the aging of the world population and the increase in obesity and metabolic disorders, the prevalence of ocular diseases and associated visual impairment is rising rapidly. In the US alone, age-related macular degeneration affects close to 3 million people, > 2 million are diagnosed with glaucoma and > 6 million patients. These numbers are estimated to double or triple by 2050. In addition, there more than 250 inherited retinal disorders that constitute the most common cause of blindness for ages 20-45.
The objectives of the ASIP Ocular Pathobiology SIG are:
Listserv
ASIP Members are invited to participate in the Ocular Pathobiology SIG Listserv. Please email membership@asip.org to have your name and email address added to the listserv.
To send a message to the Ocular Pathobiology SIG Listserv, send your email to asipocular@asip.memberclicks.net. Please note that you must be a member of this listserv in order to send and receive messages.
Please direct all questions to: Lisa McFadden (240) 283-9712.
Alejandro Adam
Albany Medical College
Babajide Ajayi
Ajayi Crowther University
Erik Butcher
Schepens Eye Research Institute of Massachusettes Eye and Ear
Chhavi Chauhan
American Society for Investigative Pathology
DongFeng Chen
Schepens Eye Research Institute/Massachusetts Eye and Ear, Harvard Medical School
Yu Holly Chen
University of Alabama at Birmingham
Charleen Chu
University of Pittsburgh School of Medicine
Patricia D'Amore
Schepens Eye Research Institute of Mass. Eye & Ear, Harvard Medical School
Darlene Dartt
Harvard Medical School
Astra Dinculescu
University of Florida
Malia Edwards
Johns Hopkins University School of Medicine
Krystal English
UT McGovern Medical School
Vivienne Fang
Northwestern University Feinberg School of Medicine
Reina Fuji
Genentech
Ana Arcia Franchini
University of Alabama
Gopalan Gnanaguru
Tufts University/Tufts School of Medicine
Urvi Gupta
Case Western Reserve University School of Medicine
Jeffrey Hofmann
Genentech
Zhengping Hu
Schepens Eye Research Institute of Massachusetts Eye and Ear
Taysha Jimenez-Rivera
University of Puerto Rico, School of Medicine
Anton Lennikov
Schepens Eye Research Institute
Emma Lessieur
University of California-Irvine
Goldis Malek
Duke University
Robert Mullins
University of Iowa Institute for Vision Research
Abiodun Oluwatoba
Children's Hospital New Orleans
Priyamvada Pitale
Baylor College of Medicine
Magali Saint-Geniez
Novartis
Daisy Shu
University of New South Wales (UNSW) Sydney
Aarathi Sureshkumar
Iowa State University
Vincent Thai
Stanford University
Susannah Waxman
University of Pittsburgh
Keith Wharton
Roche
Cecelia Yates
University of Pittsburgh
Jingjing You
University of Sydney